Fear of cancer recurrence across the survivorship trajectory: Results from a survey of adult long‐term cancer survivors
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Objective: Our study analysed fear of cancer recurrence (FoR) in long‐term cancer survivors in relation to medical variables, depression, anxiety, and quality of life. Methods: We present data obtained from 1,002 cancer survivors (53% male, mean age=68 years, 26% prostate cancer, 22% breast cancer) across all cancer types 5 (N=660) and 10 (N=342) years after diagnosis, who were recruited via a large Clinical Cancer Registry in Germany in a cross‐sectional study. FoR, depression, and anxiety were measured using validated self‐report questionnaires (12‐item short version of the Fear of Progression Questionnaire [FoP‐Q‐SF], Patient Health Questionnaire‐9 [PHQ‐9[, and General Anxiety Disorder‐7 [GAD‐7]). Hierarchical regression models were carried out with FoR as dependent variable and time since diagnosis as control variable. Results: We found high FoR‐values in 17% of the cancer survivors (FoP‐Q‐SF total score>33). FoR was higher in the 5‐year cohort (P=.028, d=0.153). Cancer survivors were most worried about the future of the family; they report being nervous prior to doctor's appointment and being afraid of relying on strangers help. Higher FoR was related to female gender (Beta=.149, P<.001), younger age (Beta=‐.103, P<.001), low social (Beta=‐.129, P<.001) and emotional functioning (Beta=‐.269, P<.001), received hormone therapy (P=.025, d=0.056), and high anxiety levels (Beta=.227, P<.001). Conclusions: Even though FoR declines slightly over time, it is still a common mental health problem for long‐term survivors even 10 years after cancer diagnosis. Since FoR is associated with reduced emotional and social quality of life, patients who are at greater risk of experiencing FoR must be identified and supported. Particularly at risk are younger women who received hormone therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Spitzer, R. L. (1999) · JAMA · doi:10.1001/jama.282.18.1737 · Cited by 9,802
Leventhal, H., Diefenbach, M., & Leventhal, E. A. (1992) · Cognitive Therapy and Research · doi:10.1007/bf01173486 · Cited by 1,573
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
Simard, S., Thewes, B., Humphris, G., Dixon, M., Hayden, C., Mireskandari, S., & Ozakinci, G. (2013) · Journal of Cancer Survivorship · doi:10.1007/s11764-013-0272-z · Cited by 1,217 · cited 13×
“The results demonstrate that FoR is a common response to a cancer diagnosis and the associated treatments; 17% of the long‐term cancer survivors reported high FoR.”
BackgroundMethodResultInfluentialSimard, S., & Savard, J. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0444-y · Cited by 608
Lebel, S., Ozakinci, G., Humphris, G., Mutsaers, B., Thewes, B., Prins, J., Dinkel, A., Butow, P., & on behalf of the University of Ottawa Fear of Cancer Recurrence Colloquium attendees (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3272-5 · Cited by 586
Koch, L., Jansen, L., Brenner, H., & Arndt, V. (2013) · Psycho-Oncology · doi:10.1002/pon.3022 · Cited by 511
Deimling, G. T., Bowman, K. F., Sterns, S., Wagner, L. J., & Kahana, B. (2006) · Psycho-Oncology · doi:10.1002/pon.955 · Cited by 496 · cited 1×
“FoR has consistently been identified in the literature as being associated with anxiety and depression, although the study designs used did not allow for causality statements and the direction of this relationship.(16,18) Other studies also identified an association between FoR and intrusive thoughts or increased prev…”
ResultFactors reported to influence fear of recurrence in cancer patients: a systematic review
Crist, J. V., & Grunfeld, E. A. (2013) · Psycho-Oncology · doi:10.1002/pon.3114 · Cited by 431
Mehnert, A., Herschbach, P., Berg, P., Henrich, G., & Koch, U. (2006) · Zeitschrift für Psychosomatische Medizin und Psychotherapie · doi:10.13109/zptm.2006.52.3.274 · Cited by 365 · cited 4×
“We used the 12‐item short version of the Fear of Progression Questionnaire (FoP‐Q‐SF).(7) The FoP‐Q is a validated, reliable instrument, developed by Herschbach et al to measure FoR in chronically ill persons.”
BackgroundMethodInfluentialSymptom Burden and Quality of Life in Survivorship: A Review of the Literature
Wu, H.-S., & Harden, J. K. (2015) · Cancer Nursing · doi:10.1097/ncc.0000000000000135 · Cited by 329
Fear of progression in chronic diseases
Herschbach, P., Berg, P., Dankert, A., Duran, G., Engst-Hastreiter, U., Waadt, S., Keller, M., Ukat, R., & Henrich, G. (2005) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2005.02.007 · Cited by 312 · cited 1×
“The FoP‐Q is a validated, reliable instrument, developed by Herschbach et al to measure FoR in chronically ill persons.(5) In a systematic review of Thewes et al on all current multi‐item self‐report questionnaires that assess FoR in cancer patients, the FoP‐Q received the highest total quality rating of all instrumen…”
MethodFear of cancer recurrence: a systematic literature review of self‐report measures
Thewes, B., Butow, P., Zachariae, R., Christensen, S., Simard, S., & Gotay, C. (2012) · Psycho-Oncology · doi:10.1002/pon.2070 · Cited by 262
A family‐based model to predict fear of recurrence for cancer survivors and their caregivers
Mellon, S., Kershaw, T. S., Northouse, L. L., & Freeman‐Gibb, L. (2007) · Psycho-Oncology · doi:10.1002/pon.1074 · Cited by 204
Sarkar, S., Scherwath, A., Schirmer, L., Schulz-Kindermann, F., Neumann, K., Kruse, M., Dinkel, A., Kunze, S., Balck, F., Kröger, N., et al. (2014) · Bone Marrow Transplantation · doi:10.1038/bmt.2014.139 · Cited by 102
Fear of cancer recurrence and its predictors among cervical cancer survivors
Hanprasertpong, J., Geater, A., Jiamset, I., Padungkul, L., Hirunkajonpan, P., & Songhong, N. (2017) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2017.28.e72 · Cited by 86 · cited 1×
“Those studies found patients to be concerned about the sadness and worries induced in family members,(36) family disruption,(38) and the economic burden placed on their spouses or children who need to take care of their loved ones.(37,39) Large proportions of patients in our sample are ≥65 years and may have already r…”
BackgroundConceptualization of disease timeline predicts posttreatment distress in breast cancer patients
Rabin, C., Leventhal, H., & Goodin, S. (2004) · Health Psychology · doi:10.1037/0278-6133.23.4.407 · Cited by 80 · cited 1×
“The theoretical model based on Leventhal's Self‐Regulation Model of Illness(31) has been supported by Rabin et al showing that FoR in breast cancer patients was significantly influenced by the patients' perceived timeline of cancer.(32) For instance, patients who believed their disease to be chronic showed higher leve…”
MethodLiu, J., Peh, C.-X., Simard, S., Griva, K., & Mahendran, R. (2018) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2018.06.004 · Cited by 72 · cited 1×
“FoR has consistently been identified in the literature as being associated with anxiety and depression, although the study designs used did not allow for causality statements and the direction of this relationship.(16,18) Other studies also identified an association between FoR and intrusive thoughts or increased prev…”
Result
Research works printed but not linked: 23
- 10.1002/cncr.29244 · DOI · Paper page
- 10.1200/JCO.2017.72.8212 · DOI · Paper page
- Mehnert A, 2006, Fear of progression in breast cancer patients‐validation of the short form of the Fear of Progression Questionnaire (FoP‐Q‐SF), Z Psychosom Med Psychother, 52, 274
- 10.1002/pon.3659 · DOI · Paper page
- 10.1016/j.cpr.2017.06.003 · DOI
- 10.1007/s00520-016-3317-9 · DOI · Paper page
- 10.1002/pon.1481 · DOI · Paper page
- Hewitt ME, 2006, From cancer patient to cancer survivor: lost in transition
- 10.1002/pon.4008 · DOI · Paper page
- 10.1002/pon.4731 · DOI
- 10.1002/cncr.25740 · DOI · Paper page
- 10.1002/pon.4224 · DOI · Paper page
- 10.1007/s00520-014-2513-8 · DOI · Paper page
- Ganz PA, 2008, Psychological and social aspects of breast cancer, Oncology (Williston Park), 22, 642
- 10.1026/0012-1924.50.4.171 · DOI · Paper page
- Borenstein M, 2012, Introduction to meta‐analysis
- 10.3109/0284186X.2013.765063 · DOI · Paper page
- 10.1002/(SICI)1099-1611(199706)6:2<95::AID-PON250>3.0.CO;2-B · doi:10.1002/(sici)1099-1611(199706)6:2<95::aid-pon250>3.0.co;2-b
- 10.1007/s00520-007-0296-x · DOI
- 10.1017/S1478951515000127 · DOI · Paper page
- 10.1007/s11764-016-0570-3 · DOI
- 10.1007/s00520-018-4291-1 · DOI
- 10.1002/pon.1604 · DOI · Paper page
Cited by
Luigjes‐Huizer, Y. L., Tauber, N. M., Humphris, G., Kasparian, N. A., Lam, W. W. T., Lebel, S., Simard, S., Smith, A. B., Zachariae, R., Afiyanti, Y., et al. (2022) · Psycho-Oncology · doi:10.1002/pon.5921 · Cited by 332
Factors Correlated With Fear of Cancer Recurrence in Cancer Survivors: A Meta-analysis
Zhang, X., Sun, D., Qin, N., Liu, M., Jiang, N., & Li, X. (2022) · Cancer Nursing · doi:10.1097/ncc.0000000000001020 · Cited by 90
Benefits and challenges of cancer peer support groups: A systematic review of qualitative studies
Jablotschkin, M., Binkowski, L., Markovits Hoopii, R., & Weis, J. (2022) · European Journal of Cancer Care · doi:10.1111/ecc.13700 · Cited by 88
Lyu, M., Siah, R. C., Lam, A. S. L., & Cheng, K. K. F. (2022) · Journal of Advanced Nursing · doi:10.1111/jan.15321 · Cited by 77
Pang, C., & Humphris, G. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.640866 · Cited by 59
Metadata
- Authors
- Götze, H., Taubenheim, S., Dietz, A., Lordick, F., & Mehnert‐Theuerkauf, A.
- Venue
- Psycho-Oncology
- Publisher
- Wiley
- Published
- 2019-08-15
- Volume
- 28
- Issue
- 10
- Pages
- 2033-2041
- ISSN
- 1057-9249 (ISSN-L)
- 1099-1611
- OpenAlex
- W2964474745
- Cited by
- 147
- References
- 18
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.